ALCHEMIA'S CEO DEPARTS

ALCHEMIA'S CEO DEPARTS
ALCHEMIA (ASX: ACL) is getting a new face.

The drug discovery and development company has announced the departure of Thomas Liquard as CEO.

In the interim, former ACL CEO Tracie Ramsdale will step up from a non-executive director role into an executive director capacity.

The company noted in an announcement that Ramsdale’s leadership will help them during this transition, and ended with thanking Liquard “for his efforts and wishing him well for the future”.


Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Advertisement

Related Stories

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Federal Court finds Google misled consumers on data collection

Federal Court finds Google misled consumers on data collection

The Federal Court has found Google misled consumers about persona...

Redflow charging up ahead of next-gen battery launch

Redflow charging up ahead of next-gen battery launch

Redflow (ASX: RFX) is gearing up to launch the next generation of...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...